Cleared Traditional

K240871 - Synxess Neurovascular Guidewire

K240871 is an FDA 510(k) clearance for Synxess Neurovascular Guidewire, manufactured by Enlight Medical Technologies (Shenzhen) Co., Ltd.. The device is a Class 2 Neurology device with product code MOF cleared through the Traditional 510(k) pathway after a 234-day FDA review.

K240871 · Enlight Medical Technologies (Shenzhen) Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2024
Decision
234d
Days
Class 2
Risk

K240871 is an FDA 510(k) clearance for the Synxess Neurovascular Guidewire. Classified as Guide, Wire, Catheter, Neurovasculature (product code MOF), Class II - Special Controls.

Submitted by Enlight Medical Technologies (Shenzhen) Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on November 18, 2024 after a review of 234 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Enlight Medical Technologies (Shenzhen) Co., Ltd. devices

FDA 510(k) Submission Details - K240871

510(k) Number K240871 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 29, 2024
Decision Date November 18, 2024
Days to Decision 234 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
86d slower than avg
Panel avg: 148d · This submission: 234d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MOF Device Classification - Class 2, Special Controls

Product Code MOF Guide, Wire, Catheter, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - MOF Guide, Wire, Catheter, Neurovasculature

All 38
Devices cleared under the same product code (MOF) and FDA review panel - the closest regulatory comparables to K240871.
0.014” Willow Guidewire
K243756 · Arbor Endovascular, LLC · Jul 2025
CHIKAI Nexus 014
K243383 · Asahi Intecc Co., Ltd. · Apr 2025
Aristotle 14 Guidewire
K243938 · Scientia Vascular, Inc. · Apr 2025
Drivewire 24 Guidewire
K233791 · Rapid Medical , Ltd. · Jul 2024
Aristotle 18 Guidewire
K231954 · Scientia Vascular, Inc. · Aug 2023
SmartGUIDE deflectable hydrophilic guidewire
K222690 · Artiria Medical SA · Apr 2023